Colgate-Palmolive Company (NYSE:CL) today reported worldwide Net sales
of $4,361 million in fourth quarter 2013, an increase of 2.0% versus
fourth quarter 2012. Global unit volume grew 6.5%, pricing was even with
the year ago quarter and foreign exchange was negative 4.5%. Organic
sales (Net sales excluding foreign exchange, acquisitions and
divestments) grew 6.5%.
Net income and Diluted earnings per share in fourth quarter 2013 were
$564 million and $0.60, respectively. Net income in fourth quarter 2013
included $133 million ($0.15 per diluted share) of aftertax charges
resulting from the implementation of the previously disclosed four-year
Global Growth and Efficiency Program (the “2012 Restructuring Program”),
a charge associated with an existing European competition law matter and
costs associated with the sale of land in Mexico.
Net income and Diluted earnings per share in fourth quarter 2012 were
$598 million and $0.63, respectively. Net income in fourth quarter 2012
included aftertax charges of $73 million ($0.07 per diluted share)
resulting from the items described in Table 8.
Excluding the above noted items in both periods, Net income in fourth
quarter 2013 was $697 million, an increase of 4% versus fourth quarter
2012, and Diluted earnings per share in fourth quarter 2013 was $0.75,
an increase of 7% versus fourth quarter 2012.
Gross profit margin was 58.9% in fourth quarter 2013 versus 58.4% in the
year ago quarter. Excluding the above noted items in both periods, Gross
profit margin was 59.1% in fourth quarter 2013, an increase of 50 basis
points versus the year ago quarter, as cost savings from the Company’s
funding-the-growth initiatives more than offset higher raw and packaging
material costs which included the impact of foreign exchange transaction
costs.
Selling, general and administrative expenses were 37.0% of Net sales in
fourth quarter 2013 versus 34.7% of Net sales in fourth quarter 2012.
Excluding the above noted items in both periods, Selling, general and
administrative expenses decreased by 10 basis points to 34.5% of Net
sales in fourth quarter 2013, as an increase in advertising investment
was more than offset by a decrease in overhead expenses, both as a
percentage of Net sales. Worldwide advertising investment increased 3%
versus the year ago quarter to $445 million.
Operating profit decreased 5% to $892 million in fourth quarter 2013
compared to $942 million in fourth quarter 2012. Excluding the above
noted items in both periods, Operating profit increased 4% to $1,074
million.
Net cash provided by operations year to date was $3,204 million compared
to $3,196 million in the comparable 2012 period, as strong operating
earnings and a continued tight focus on working capital were offset by
higher cash spending related to the 2012 Restructuring Program. Free
cash flow before dividends (Net cash provided by operations less Capital
expenditures) exceeded 100% of Net income. Working capital as a
percentage of Net sales was 0.7%, even with the year ago period.
For the full year 2013, worldwide Net sales were $17,420 million, up
2.0% versus full year 2012. Global unit volume grew 5.0%, pricing
increased 1.0% and foreign exchange was negative 4.0%. Organic sales
grew 6.0%.
Net income and Diluted earnings per share for full year 2013 were $2,241
million and $2.38, respectively. Full year 2013 results include $424
million ($0.46 per diluted share) of aftertax charges resulting from the
implementation of the 2012 Restructuring Program, the one-time charge
relating to the remeasurement of the Venezuela balance sheet as a result
of the currency devaluation in Venezuela, a charge associated with a
European competition law matter and costs associated with the sale of
land in Mexico.
Net income and Diluted earnings per share for full year 2012 were $2,472
million and $2.57, respectively. As previously disclosed, full year 2012
results included net aftertax charges of $102 million ($0.11 per diluted
share) resulting from the items described in Table 9.
Excluding the items noted above in both periods, Net income for full
year 2013 increased 4% versus full year 2012 and Diluted earnings per
share increased 6% versus full year 2012.
Gross profit margin was 58.6% for full year 2013 versus 58.1% in full
year 2012. Excluding the items noted above in both periods, Gross profit
margin was 58.8% in full year 2013, up 50 basis points versus full year
2012, as higher pricing and cost savings from the Company’s
funding-the-growth initiatives more than offset the impact of increases
in raw and packaging material costs and foreign exchange transaction
costs.
Ian Cook, Chairman, President and Chief Executive Officer, commented on
the results and outlook excluding the 2013 and 2012 items noted above,
“We are delighted to have ended the year with another quarter of strong
growth on both the top and bottom lines. For the eleventh consecutive
quarter, operating profit, net income and diluted earnings per share all
increased versus the year ago period.
“The strong 6.5% organic sales growth was led by the emerging markets,
where organic sales grew a robust 10.5%. Our strong top-line momentum
should continue into 2014, fueled by new products across all categories
and in all geographies.
“Pleasingly, the increase in gross profit margin during the quarter,
combined with a reduction in overhead costs funded an increase in
advertising spending behind Colgate’s brands, both absolutely and as a
percent to sales, driving market share performance worldwide.
“Colgate’s leading global market shares in toothpaste and manual
toothbrushes remain strong at 44.9% and 32.8%, respectively, on a
year-to-date basis. We continue to make great progress in mouthwash as
well, with our global market share in that category reaching a record
high at 17.0% year to date, up 130 basis points versus prior year.
“Our 2012 Restructuring Program is on track and proceeding smoothly. We
also continue to be sharply focused on our aggressive worldwide
funding-the-growth programs and our strategic pricing initiatives.”
Mr. Cook concluded, “As we look ahead to 2014, based on the Company’s
current growth momentum and our confidence in the strength of our global
growth and efficiency program, we are planning for a year of gross
margin expansion and strong earnings per share growth in line with the
consensus of external analyst estimates, excluding charges related to
the 2012 Restructuring Program. This takes into account recent movements
in foreign exchange rates but excludes the impact of the recent economic
announcements in Venezuela, which we are still evaluating.”
At 11:00 a.m. ET today, Colgate will host a conference call to elaborate
on fourth quarter results. To access this call as a webcast, please go
to Colgate’s web site at http://www.colgatepalmolive.com.
The following are comments about divisional performance for fourth
quarter 2013 versus the year ago period. See attached Geographic Sales
Analysis Percentage Changes and Segment Information schedules for
additional information on divisional net sales and operating profit.
North America (18% of Company Sales)
North America Net sales increased 2.5% in fourth quarter 2013. Unit
volume increased 4.0% with 1.0% lower pricing and 0.5% negative foreign
exchange. Organic sales increased 3.0% during the quarter.
Operating profit in North America increased 5% in fourth quarter 2013 to
$241 million, or 70 basis points to 31.2% of Net sales. This increase in
Operating profit was primarily due to an increase in Gross profit, which
was partially offset by an increase in Selling, general and
administrative expenses, both as a percentage of Net sales. This
increase in Gross profit was mainly driven by cost savings from the
Company’s funding-the-growth initiatives, which were partially offset by
higher raw and packaging material costs and lower pricing. This increase
in Selling, general and administrative expenses was driven by increased
advertising investment, which more than offset lower overhead expenses.
In the U.S., new product launches are contributing to volume growth
across categories. Market share gains year to date were seen in manual
toothbrushes, powered toothbrushes, mouthwash, dish liquids and fabric
conditioners. In toothpaste, the success of Colgate Optic White and
Colgate Optic White Dual Action toothpastes helped drive market share
for the Colgate Optic White brand to 5.3% year to date, up 0.2 share
points versus year ago. Strong sales of Colgate Total, Colgate Max Fresh
Cool Scrub, Colgate Sensitive SmartFoam with Whitening and Tom’s of
Maine toothpastes also contributed to volume growth in the quarter.
In manual toothbrushes, Colgate continued its brand market leadership
with its market share in that category reaching a record 38.1% year to
date, up 2.1 share points versus year ago. This success was driven by
strong sales of Colgate 360° Optic White, Colgate 360° Total Advanced
Floss Tip bristles, Colgate Extra Clean and Colgate Slim Soft manual
toothbrushes.
Successful products driving volume growth in the U.S. in other
categories include Colgate Total Advanced Pro-Shield and Colgate Optic
White mouthwashes, Palmolive Soft Touch and Palmolive Lotus Blossom &
Lavender dish liquids and Suavitel fabric conditioner.
Exciting new products planned for launch in first quarter 2014 include
Colgate Optic White manual toothbrush + built-in whitening pen, Colgate
Optic White Platinum Whiten and Protect toothpaste, Speed Stick Gear
deodorants with new DryCore technology, Softsoap brand Décor Collection
liquid hand soaps, Suavitel Fast Dry fabric conditioner and Palmolive
Dish & Sink dish washing liquid.
Latin America (29% of Company Sales)
Latin America Net sales increased 1.0% in fourth quarter 2013. Unit
volume increased 10.0% with 2.5% higher pricing and 11.5% negative
foreign exchange. Volume gains were led by Venezuela, Brazil, Mexico and
Colombia. Organic sales for Latin America increased 12.5% during the
quarter.
Operating profit in Latin America increased 3% in fourth quarter 2013 to
$363 million, or 50 basis points to 28.7% of Net sales. This increase in
Operating profit was primarily due to a decrease in Selling, general and
administrative expenses, which was partially offset by a decrease in
Gross profit, both as a percentage of Net sales. This decrease in Gross
profit was due to higher costs, primarily in Venezuela, which were
partially offset by cost savings from the Company’s funding-the-growth
initiatives and the benefits of pricing. This decrease in Selling,
general and administrative expenses was due to lower overhead expenses
and decreased advertising investment, the latter due to the timing of
new product launches.
Colgate’s strong leadership in oral care throughout Latin America
continued during the quarter with year-to-date toothpaste market share
gains in Brazil, Chile, Uruguay, the Dominican Republic and Puerto Rico.
Strong sales of Colgate Luminous White, Colgate Luminous White Advanced,
Colgate Total Professional Gum Health and Colgate Maximum Cavity
Protection plus Neutrazucar toothpastes drove volume growth throughout
the region. Colgate strengthened its leadership of the manual toothbrush
market throughout the region, driven by strong sales of Colgate 360°
Luminous White, Colgate Triple Action and Colgate Premier Clean manual
toothbrushes. In mouthwash, Colgate’s strong market share performance
continues throughout the region, driven by the success of Colgate
Luminous White, Colgate Plax Fresh Tea and Colgate Plax 2 in 1
mouthwashes.
Products in other categories contributing to volume growth include
Protex Men, Protex Vitamin E, Palmolive Naturals Olive and Aloe and
Palmolive Naturals Argan Oil bar soaps and Axion Oats dish liquid.
Europe/South Pacific (19% of Company Sales)
Europe/South Pacific Net sales decreased 0.5% in fourth quarter 2013.
Unit volume increased 2.5% with 4.5% lower pricing and 1.5% positive
foreign exchange. Excluding divested businesses, unit volume increased
3.0%. Volume gains in the United Kingdom, Australia and Poland more than
offset volume declines in France and Germany. Organic sales for
Europe/South Pacific decreased 1.5%.
Operating profit in Europe/South Pacific increased 7% in fourth quarter
2013 to $200 million, or 160 basis points to 23.7% of Net sales. This
increase in Operating profit was primarily due to an increase in Gross
profit, which was partially offset by an increase in Selling, general
and administrative expenses, both as a percentage of Net sales. This
increase in Gross profit was primarily driven by savings from the
Company’s funding-the-growth initiatives, which were partially offset by
lower pricing. This increase in Selling, general and administrative
expenses was driven by increased advertising investment, which was
partially offset by lower overhead expenses.
Colgate strengthened its oral care leadership in the Europe/South
Pacific region with toothpaste share gains led by the United Kingdom,
Switzerland, Poland, Germany, Austria, Czech Republic, the Netherlands,
Croatia and Serbia. Successful premium products driving share gains
include Colgate Max White One Luminous, Colgate Max Fresh ActiClean with
SmartFoam and Colgate Total Pro Interdental toothpastes. In the manual
toothbrush category, Colgate 360° Interdental and Colgate Slim Soft
manual toothbrushes contributed to volume growth throughout the region.
Recent premium innovations contributing to volume growth in other
product categories include Colgate Max White One and Colgate Plax
Complete Care mouthwashes, Colgate ProClinical electric toothbrush,
Sanex Surgras and Palmolive Mediterranean Moments shower gels, Palmolive
Hygiene-Plus liquid hand soap, Paic Excel + dish liquid and Soupline
Perfect Glide fabric conditioner.
Asia (14% of Company Sales)
Asia Net sales increased 4.5% during fourth quarter 2013. Unit volume
increased 10.5% with 1.5% lower pricing and 4.5% negative foreign
exchange. Volume gains were led by the Greater China region, India and
the Philippines. Organic sales for Asia increased 9.0%.
Operating profit in Asia increased 14% in fourth quarter 2013 to $165
million, or 230 basis points to 28.8% of Net sales. This increase in
Operating profit was primarily due to an increase in Gross profit and a
decrease in Selling, general and administrative expenses, both as a
percentage of Net sales. This increase in Gross profit was primarily due
to cost savings from the Company’s funding-the-growth initiatives,
partially offset by higher raw and packaging material costs, which
included foreign exchange transaction costs, and lower pricing. This
decrease in Selling, general and administrative expenses was primarily
due to lower overhead expenses and decreased advertising investment, the
latter due to the timing of new product launches.
Colgate strengthened its toothpaste leadership in Asia, driven by market
share gains in India, China, Thailand, the Philippines and Singapore.
Successful new products including Colgate Total Pro Gum Health, Colgate
Optic White, Colgate Visible White, Colgate Active Salt Healthy White,
Darlie Expert White and Colgate Max Fresh Tea toothpastes contributed to
volume growth throughout the region.
Successful new products contributing to volume growth in other
categories in the region include Colgate Slim Soft Charcoal and Colgate
Slim Soft Raised Tip manual toothbrushes, Colgate Optic White, Colgate
Plax Fruity Fresh and Darlie mouthwashes, Palmolive Naturals White +
Milk bar soap, Protex Men Power shower gel and Palmolive Naturals
Vibrant Color shampoo.
Africa/Eurasia (7% of Company Sales)
Africa/Eurasia Net sales increased 0.5% during fourth quarter 2013. Unit
volume increased 6.0% with 1.0% higher pricing and 6.5% negative foreign
exchange. Volume gains were led by Russia, the Sub-Saharan Africa
region, Turkey and the Central Asia/Caucasus region. Organic sales for
Africa/Eurasia increased 7.0%.
Operating profit in Africa/Eurasia increased 9% in fourth quarter 2013
to $76 million, or 170 basis points to 23.4% of Net sales. This increase
in Operating profit was primarily due to an increase in Gross profit and
a decrease in Selling, general and administrative expenses, both as a
percentage of Net sales. This increase in Gross profit was primarily due
to cost savings from the Company’s funding-the-growth initiatives and
the benefits of pricing, partially offset by higher raw and packaging
material costs, which included foreign exchange transaction costs. This
decrease in Selling, general and administrative expenses was primarily
due to lower overhead expenses which were partially offset by increased
advertising investment.
Colgate continued its toothpaste leadership in Africa/Eurasia, driven by
market share gains in Russia, South Africa, Turkey, Kenya, Saudi Arabia
and Kuwait. Successful products contributing to volume growth in the
region include Colgate Optic White, Colgate Altai Herbs, Colgate Total
Pro Interdental and Colgate Maximum Cavity Protection plus Sugar Acid
Neutralizer toothpastes, Colgate 360° Optic White and Colgate Slim Soft
Charcoal manual toothbrushes, Colgate Optic White and Colgate Plax
Herbal mouthwashes and Palmolive Gourmet Spa and Protex for Men shower
gels.
Hill’s Pet Nutrition (13% of Company Sales)
Hill’s Net sales increased 4.5% during fourth quarter 2013. Unit volume
increased 4.0% with 3.0% higher pricing and 2.5% negative foreign
exchange. Volume gains in the U.S., Russia and Canada were partially
offset by volume declines in Japan. Hill’s organic sales increased 7.0%.
Hill’s Operating profit increased 3% in fourth quarter 2013 to $153
million, while as a percentage of Net sales it decreased 50 basis points
to 26.2% of Net sales. This decrease in Operating profit as a percentage
of Net sales was primarily due to a decrease in Gross profit, which was
partially offset by a decrease in Selling, general and administrative
expenses, both as a percentage of Net sales. This decrease in Gross
profit was primarily driven by higher raw and packaging material costs,
due in part to formulation changes and foreign exchange transaction
costs, which were partially offset by cost savings from the Company’s
funding-the-growth initiatives and the benefit of pricing. This decrease
in Selling, general and administrative expenses was due to lower
overhead expenses and decreased advertising investment, the latter due
to timing of new product launches.
New product introductions driving volume growth in the U.S. include the
recent successful launch of our natural pet food brand, Hill’s Ideal
Balance, with natural ingredients perfectly balanced.
New product introductions driving volume growth globally include the
launch of breakthrough weight loss nutrition, Hill’s Prescription Diet
Metabolic, and the relaunch of Hill’s Science Diet with natural
ingredients and improved taste.
Exciting new products planned for launch in first quarter 2014 include
Hill’s Ideal Balance Active and Slim & Healthy, Hill’s Science Diet
Grain Free, Perfect Weight and Sensitive Stomach and Skin, and Hill’s
Prescription Diet c/d Urinary Stress.
***
About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer
products company, tightly focused on Oral Care, Personal Care, Home Care
and Pet Nutrition. Colgate sells its products in over 200 countries and
territories around the world under such internationally recognized brand
names as Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap,
Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom’s of Maine, Sanex,
Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science
Diet, Hill’s Prescription Diet and Hill’s Ideal Balance. For more
information about Colgate’s global business, visit the Company’s web
site at http://www.colgatepalmolive.com.
To learn more about Colgate Bright Smiles, Bright Futures® oral health
education program, please visit http://www.colgatebsbf.com.
CL-E
The Company’s annual meeting of shareholders is currently scheduled for
Friday, May 9, 2014.
Market Share Information
Management uses market share information as a key indicator to monitor
business health and performance. References to market share in this
press release are based on a combination of consumption and market share
data provided by third-party vendors, primarily Nielsen, and internal
estimates. All market share references represent the percentage of the
dollar value of sales of our products, relative to all product sales in
the category in the countries in which the Company competes and
purchases data. Market share data is subject to limitations on the
availability of up-to-date information. We believe that the third-party
vendors we use to provide data are reliable, but we have not verified
the accuracy or completeness of the data or any assumptions underlying
the data. In addition, market share information calculated by the
Company may be different from market share information calculated by
other companies due to differences in category definitions, the use of
data from different countries, internal estimates and other factors.
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast may contain forward-looking
statements. Such statements may relate, for example, to sales or volume
growth, organic sales growth, profit or profit margin growth, earnings
growth, financial goals, the impact of currency devaluations, exchange
controls, price controls and labor unrest, including in Venezuela,
cost-reduction plans including the 2012 Restructuring Program, tax
rates, new product introductions or commercial investment levels. These
statements are made on the basis of our views and assumptions as of this
time and we undertake no obligation to update these statements. We
caution investors that any such forward-looking statements are not
guarantees of future performance and that actual events or results may
differ materially from those statements. Investors should consult the
Company’s filings with the Securities and Exchange Commission (including
the information set forth under the caption “Risk Factors” in the
Company’s Annual Report on Form 10-K for the year ended December 31,
2012) for information about certain factors that could cause such
differences. Copies of these filings may be obtained upon request from
the Company’s Investor Relations Department or on the Company’s web site
at http://www.colgatepalmolive.com.
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial
measures used in this earnings release and/or the related webcast:
This release discusses organic sales growth, which is Net sales growth
excluding the impact of foreign exchange, acquisitions and divestments.
Management believes this measure provides investors with useful
supplemental information regarding the Company’s underlying sales trends
by presenting sales growth excluding the external factor of foreign
exchange as well as the impact from acquisitions and divestments. See
“Geographic Sales Analysis Percentage Changes” for the three and twelve
months ended December 31, 2013 vs 2012 included with this release for a
comparison of organic sales growth to sales growth in accordance with
accounting principles generally accepted in the United States of America
(“GAAP”).
To supplement Colgate’s Condensed Consolidated Income Statements
presented in accordance with GAAP, the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Worldwide
Gross profit, Gross profit margin, Selling, general and administrative
expenses, Selling, general and administrative expenses as a percentage
of Net sales, Other (income) expense, net, Operating profit, Operating
profit margin, Net income attributable to Colgate-Palmolive Company and
Diluted earnings per common share are discussed both as reported (on a
GAAP basis) and, as applicable, excluding charges resulting from the
implementation of the 2012 Restructuring Program, the one-time charge
resulting from the Venezuela devaluation, a charge associated with a
European competition law matter, costs related to the sale of land in
Mexico and costs associated with various business realignment and other
cost-saving initiatives (non-GAAP). Management believes these non-GAAP
financial measures provide investors with useful supplemental
information regarding the performance of the Company’s ongoing
operations. See “Non-GAAP Reconciliations” for the three and twelve
months ended December 31, 2013 and 2012 included with this release for a
reconciliation of these financial measures to the related GAAP measures.
The Company uses these financial measures internally in its budgeting
process and as factors in determining compensation. While the Company
believes that these financial measures are useful in evaluating the
Company’s business, this information should be considered as
supplemental in nature and is not meant to be considered in isolation or
as a substitute for the related financial information prepared in
accordance with GAAP. In addition, these non-GAAP financial measures may
not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as Net cash provided
by operations less Capital expenditures. As management uses this measure
to evaluate the Company’s ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is not a GAAP
measurement and may not be comparable to similarly titled measures
reported by other companies. See “Condensed Consolidated Statements of
Cash Flows” for the twelve months ended December 31, 2013 and 2012 for a
comparison of free cash flow before dividends to Net cash provided by
operations as reported in accordance with GAAP.
(See attached tables for fourth quarter results.)
|
Table 1
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Income Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended December 31, 2013 and 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Millions Except Per Share Amounts) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
|
|
|
$
|
4,361
|
|
|
|
|
|
$
|
4,286
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
|
|
|
|
1,794
|
|
|
|
|
|
|
1,781
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
2,567
|
|
|
|
|
|
|
2,505
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit margin
|
|
|
|
|
|
|
58.9%
|
|
|
|
|
|
|
58.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
|
|
|
|
1,612
|
|
|
|
|
|
|
1,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (income) expense, net
|
|
|
|
|
|
|
63
|
|
|
|
|
|
|
76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
|
|
|
|
|
892
|
|
|
|
|
|
|
942
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit margin
|
|
|
|
|
|
|
20.5%
|
|
|
|
|
|
|
22.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest (income) expense, net
|
|
|
|
|
|
|
(1)
|
|
|
|
|
|
|
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
|
|
|
|
893
|
|
|
|
|
|
|
947
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
|
|
|
|
292
|
|
|
|
|
|
|
311
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
|
|
|
|
32.7%
|
|
|
|
|
|
|
32.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income including noncontrolling interests
|
|
|
|
|
|
|
601
|
|
|
|
|
|
|
636
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interests
|
|
|
|
|
|
|
37
|
|
|
|
|
|
|
38
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Colgate-Palmolive Company
|
|
|
|
|
|
$
|
564
|
|
|
|
|
|
$
|
598
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
|
$
|
0.61
|
|
|
|
|
|
$
|
0.63
|
|
Diluted
|
|
|
|
|
|
$
|
0.60
|
|
|
|
|
|
$
|
0.63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average common shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
|
|
925.7
|
|
|
|
|
|
|
944.0
|
|
Diluted
|
|
|
|
|
|
|
935.3
|
|
|
|
|
|
|
952.1
|
|
Table 2
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Income Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31, 2013 and 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Millions Except Per Share Amounts) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
|
|
|
$
|
17,420
|
|
|
|
|
|
$
|
17,085
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
|
|
|
|
7,219
|
|
|
|
|
|
|
7,153
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
10,201
|
|
|
|
|
|
|
9,932
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit margin
|
|
|
|
|
|
|
58.6%
|
|
|
|
|
|
|
58.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
|
|
|
|
6,223
|
|
|
|
|
|
|
5,930
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (income) expense, net
|
|
|
|
|
|
|
422
|
|
|
|
|
|
|
113
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
|
|
|
|
|
3,556
|
|
|
|
|
|
|
3,889
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit margin
|
|
|
|
|
|
|
20.4%
|
|
|
|
|
|
|
22.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest (income) expense, net
|
|
|
|
|
|
|
(9)
|
|
|
|
|
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
|
|
|
|
3,565
|
|
|
|
|
|
|
3,874
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
|
|
|
|
1,155
|
|
|
|
|
|
|
1,243
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
|
|
|
|
32.4%
|
|
|
|
|
|
|
32.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income including noncontrolling interests
|
|
|
|
|
|
|
2,410
|
|
|
|
|
|
|
2,631
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interests
|
|
|
|
|
|
|
169
|
|
|
|
|
|
|
159
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Colgate-Palmolive Company
|
|
|
|
|
|
$
|
2,241
|
|
|
|
|
|
$
|
2,472
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
|
$
|
2.41
|
|
|
|
|
|
$
|
2.60
|
|
Diluted
|
|
|
|
|
|
$
|
2.38
|
|
|
|
|
|
$
|
2.57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average common shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
|
|
930.8
|
|
|
|
|
|
|
952.1
|
|
Diluted
|
|
|
|
|
|
|
939.9
|
|
|
|
|
|
|
960.2
|
|
Table 3
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheets
|
|
|
|
As of December 31, 2013 and 2012
|
|
|
|
|
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
|
December 31,
|
|
December 31,
|
|
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
962
|
|
$
|
884
|
|
Receivables, net
|
|
|
1,636
|
|
|
1,668
|
|
Inventories
|
|
|
1,425
|
|
|
1,365
|
|
Other current assets
|
|
|
799
|
|
|
639
|
|
Property, plant and equipment, net
|
|
|
4,083
|
|
|
3,842
|
|
Other assets, including goodwill and intangibles
|
|
|
4,971
|
|
|
4,996
|
|
Total assets
|
|
$
|
13,876
|
|
$
|
13,394
|
|
|
|
|
|
|
|
Total debt
|
|
$
|
5,657
|
|
$
|
5,230
|
|
Other current liabilities
|
|
|
3,562
|
|
|
3,432
|
|
Other non-current liabilities
|
|
|
2,121
|
|
|
2,342
|
|
Total liabilities
|
|
|
11,340
|
|
|
11,004
|
|
Total Colgate-Palmolive Company shareholders' equity
|
|
|
2,305
|
|
|
2,189
|
|
Noncontrolling interests
|
|
|
231
|
|
|
201
|
|
Total liabilities and shareholders' equity
|
|
$
|
13,876
|
|
$
|
13,394
|
|
|
|
|
|
|
|
Supplemental Balance Sheet Information
|
|
|
|
|
|
Debt less cash, cash equivalents and marketable securities*
|
|
$
|
4,522
|
|
$
|
4,230
|
|
Working capital % of sales
|
|
|
0.7 %
|
|
|
0.7 %
|
|
|
|
|
|
|
*
|
Marketable securities of $173 and $116 as of December 31, 2013 and
2012, respectively, are included in Other current assets.
|
|
Table 4
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31, 2013 and 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income including noncontrolling interests
|
|
|
|
|
|
$
|
2,410
|
|
|
|
|
|
|
$
|
2,631
|
|
|
Adjustments to reconcile net income including noncontrolling
interests to net cash provided by operations:
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
|
|
|
|
439
|
|
|
|
|
|
|
|
425
|
|
|
Restructuring and termination benefits, net of cash
|
|
|
|
|
|
|
182
|
|
|
|
|
|
|
|
35
|
|
|
Voluntary benefit plan contributions
|
|
|
|
|
|
|
(101
|
)
|
|
|
|
|
|
|
(101
|
)
|
|
Stock-based compensation expense
|
|
|
|
|
|
|
128
|
|
|
|
|
|
|
|
120
|
|
|
Venezuela devaluation charge
|
|
|
|
|
|
|
172
|
|
|
|
|
|
|
|
-
|
|
|
Deferred income taxes
|
|
|
|
|
|
|
71
|
|
|
|
|
|
|
|
63
|
|
|
Cash effects of changes in:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Receivables
|
|
|
|
|
|
|
(37
|
)
|
|
|
|
|
|
|
19
|
|
|
Inventories
|
|
|
|
|
|
|
(97
|
)
|
|
|
|
|
|
|
(21
|
)
|
|
Accounts payable and other accruals
|
|
|
|
|
|
|
24
|
|
|
|
|
|
|
|
(5
|
)
|
|
Other non-current assets and liabilities
|
|
|
|
|
|
|
13
|
|
|
|
|
|
|
|
30
|
|
|
Net cash provided by operations
|
|
|
|
|
|
|
3,204
|
|
|
|
|
|
|
|
3,196
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
(670
|
)
|
|
|
|
|
|
|
(565
|
)
|
|
Sale of property and non-core product lines
|
|
|
|
|
|
|
15
|
|
|
|
|
|
|
|
72
|
|
|
Purchases of marketable securities and investments
|
|
|
|
|
|
|
(505
|
)
|
|
|
|
|
|
|
(545
|
)
|
|
Proceeds from sale of marketable securities and investments
|
|
|
|
|
|
|
267
|
|
|
|
|
|
|
|
147
|
|
|
Payment for acquisitions, net of cash acquired
|
|
|
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
(29
|
)
|
|
Other
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
55
|
|
|
Net cash used in investing activities
|
|
|
|
|
|
|
(890
|
)
|
|
|
|
|
|
|
(865
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal payments on debt
|
|
|
|
|
|
|
(7,554
|
)
|
|
|
|
|
|
|
(5,011
|
)
|
|
Proceeds from issuance of debt
|
|
|
|
|
|
|
7,976
|
|
|
|
|
|
|
|
5,452
|
|
|
Dividends paid
|
|
|
|
|
|
|
(1,382
|
)
|
|
|
|
|
|
|
(1,277
|
)
|
|
Purchases of treasury shares
|
|
|
|
|
|
|
(1,521
|
)
|
|
|
|
|
|
|
(1,943
|
)
|
|
Proceeds from exercise of stock options and excess tax benefits
|
|
|
|
|
|
|
339
|
|
|
|
|
|
|
|
478
|
|
|
Net cash used in financing activities
|
|
|
|
|
|
|
(2,142
|
)
|
|
|
|
|
|
|
(2,301
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on Cash and cash equivalents
|
|
|
|
|
|
|
(94
|
)
|
|
|
|
|
|
|
(24
|
)
|
|
Net increase (decrease) in Cash and cash equivalents
|
|
|
|
|
|
|
78
|
|
|
|
|
|
|
|
6
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
|
884
|
|
|
|
|
|
|
|
878
|
|
|
Cash and cash equivalents at end of period
|
|
|
|
|
|
$
|
962
|
|
|
|
|
|
|
$
|
884
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental Cash Flow Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Free cash flow before dividends (Net cash provided by operations
less Capital expenditures)
|
|
|
|
|
|
|
|
|
Net cash provided by operations
|
|
|
|
|
|
$
|
3,204
|
|
|
|
|
|
|
$
|
3,196
|
|
|
Less: Capital expenditures
|
|
|
|
|
|
|
(670
|
)
|
|
|
|
|
|
|
(565
|
)
|
|
Free cash flow before dividends
|
|
|
|
|
|
$
|
2,534
|
|
|
|
|
|
|
$
|
2,631
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid
|
|
|
|
|
|
$
|
1,087
|
|
|
|
|
|
|
$
|
1,280
|
|
|
Table 5
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three and Twelve Months Ended December 31, 2013 and 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31,
|
|
|
|
|
|
Twelve Months Ended
December 31,
|
|
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
Net sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oral, Personal and Home Care
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
|
|
|
|
$
|
772
|
|
|
|
|
|
|
$
|
754
|
|
|
|
|
|
|
$
|
3,072
|
|
|
|
|
|
|
$
|
2,971
|
|
|
Latin America
|
|
|
|
|
|
|
1,265
|
|
|
|
|
|
|
|
1,255
|
|
|
|
|
|
|
|
5,012
|
|
|
|
|
|
|
|
5,032
|
|
|
Europe/South Pacific
|
|
|
|
|
|
|
844
|
|
|
|
|
|
|
|
848
|
|
|
|
|
|
|
|
3,396
|
|
|
|
|
|
|
|
3,417
|
|
|
Asia
|
|
|
|
|
|
|
572
|
|
|
|
|
|
|
|
547
|
|
|
|
|
|
|
|
2,472
|
|
|
|
|
|
|
|
2,264
|
|
|
Africa/Eurasia
|
|
|
|
|
|
|
325
|
|
|
|
|
|
|
|
323
|
|
|
|
|
|
|
|
1,257
|
|
|
|
|
|
|
|
1,241
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Oral, Personal and Home Care
|
|
|
|
|
|
|
3,778
|
|
|
|
|
|
|
|
3,727
|
|
|
|
|
|
|
|
15,209
|
|
|
|
|
|
|
|
14,925
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pet Nutrition
|
|
|
|
|
|
|
583
|
|
|
|
|
|
|
|
559
|
|
|
|
|
|
|
|
2,211
|
|
|
|
|
|
|
|
2,160
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Net sales
|
|
|
|
|
|
$
|
4,361
|
|
|
|
|
|
|
$
|
4,286
|
|
|
|
|
|
|
$
|
17,420
|
|
|
|
|
|
|
$
|
17,085
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31,
|
|
|
|
|
|
Twelve Months Ended
December 31,
|
|
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
Operating profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oral, Personal and Home Care
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
|
|
|
|
$
|
241
|
|
|
|
|
|
|
$
|
230
|
|
|
|
|
|
|
$
|
927
|
|
|
|
|
|
|
$
|
810
|
|
|
Latin America
|
|
|
|
|
|
|
363
|
|
|
|
|
|
|
|
354
|
|
|
|
|
|
|
|
1,385
|
|
|
|
|
|
|
|
1,454
|
|
|
Europe/South Pacific
|
|
|
|
|
|
|
200
|
|
|
|
|
|
|
|
187
|
|
|
|
|
|
|
|
805
|
|
|
|
|
|
|
|
747
|
|
|
Asia
|
|
|
|
|
|
|
165
|
|
|
|
|
|
|
|
145
|
|
|
|
|
|
|
|
698
|
|
|
|
|
|
|
|
619
|
|
|
Africa/Eurasia
|
|
|
|
|
|
|
76
|
|
|
|
|
|
|
|
70
|
|
|
|
|
|
|
|
268
|
|
|
|
|
|
|
|
267
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Oral, Personal and Home Care
|
|
|
|
|
|
|
1,045
|
|
|
|
|
|
|
|
986
|
|
|
|
|
|
|
|
4,083
|
|
|
|
|
|
|
|
3,897
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pet Nutrition
|
|
|
|
|
|
|
153
|
|
|
|
|
|
|
|
149
|
|
|
|
|
|
|
|
563
|
|
|
|
|
|
|
|
589
|
|
|
Corporate(1)
|
|
|
|
|
|
|
(306
|
)
|
|
|
|
|
|
|
(193
|
)
|
|
|
|
|
|
|
(1,090
|
)
|
|
|
|
|
|
|
(597
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Operating Profit
|
|
|
|
|
|
$
|
892
|
|
|
|
|
|
|
$
|
942
|
|
|
|
|
|
|
$
|
3,556
|
|
|
|
|
|
|
$
|
3,889
|
|
Note:
(1) Corporate operations includes costs related to stock
options and restricted stock awards, research and development costs,
Corporate overhead costs, restructuring and related implementation costs
and gains and losses on sales of non-core product lines and assets.
Corporate Operating profit (loss) for the three months ended December
31, 2013 includes costs of $173 associated with the 2012 Restructuring
Program, a charge of $5 for a competition law matter in France related
to the home care and personal care sectors and costs of $4 related to
the sale of land in Mexico. For the three months ended December 31,
2012, Corporate Operating profit (loss) included costs of $89 associated
with the 2012 Restructuring Program and costs of $4 related to the sale
of land in Mexico.
Corporate Operating profit (loss) for the twelve months ended December
31, 2013 includes costs of $371 associated with the 2012 Restructuring
Program, a one-time $172 charge for the impact of the devaluation in
Venezuela, a charge of $23 for a competition law matter in France
related to the home care and personal care sectors and costs of $18
related to the sale of land in Mexico. For the twelve months ended
December 31, 2012, Corporate Operating profit (loss) included costs of
$89 associated with the 2012 Restructuring Program, costs of $24 related
to the sale of land in Mexico and costs of $21 associated with various
business realignment and other cost-saving initiatives.
|
Table 6
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Geographic Sales Analysis Percentage Changes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended December 31, 2013 vs 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPONENTS OF SALES CHANGE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coupons
|
|
|
|
|
|
|
|
|
|
|
|
Sales
|
|
|
|
|
3 Months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer &
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
Organic
|
|
|
|
|
As Reported
|
|
|
|
|
Organic
|
|
|
|
|
Ex-Divested
|
|
|
|
|
Trade
|
|
|
|
|
Foreign
|
|
Region
|
|
|
|
|
As Reported
|
|
|
|
|
Sales Change
|
|
|
|
|
Volume
|
|
|
|
|
Volume
|
|
|
|
|
Volume
|
|
|
|
|
Incentives
|
|
|
|
|
Exchange
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company
|
|
|
|
|
2.0 %
|
|
|
|
|
6.5 %
|
|
|
|
|
6.5 %
|
|
|
|
|
6.5 %
|
|
|
|
|
6.5 %
|
|
|
|
|
- %
|
|
|
|
|
(4.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Europe/South Pacific
|
|
|
|
|
(0.5)%
|
|
|
|
|
(1.5)%
|
|
|
|
|
2.5 %
|
|
|
|
|
3.0 %
|
|
|
|
|
3.0 %
|
|
|
|
|
(4.5)%
|
|
|
|
|
1.5 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Latin America
|
|
|
|
|
1.0 %
|
|
|
|
|
12.5 %
|
|
|
|
|
10.0 %
|
|
|
|
|
10.0 %
|
|
|
|
|
10.0 %
|
|
|
|
|
2.5 %
|
|
|
|
|
(11.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia
|
|
|
|
|
4.5 %
|
|
|
|
|
9.0 %
|
|
|
|
|
10.5 %
|
|
|
|
|
10.5 %
|
|
|
|
|
10.5 %
|
|
|
|
|
(1.5)%
|
|
|
|
|
(4.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Africa/Eurasia
|
|
|
|
|
0.5 %
|
|
|
|
|
7.0 %
|
|
|
|
|
6.0 %
|
|
|
|
|
6.0 %
|
|
|
|
|
6.0 %
|
|
|
|
|
1.0 %
|
|
|
|
|
(6.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total International
|
|
|
|
|
1.0 %
|
|
|
|
|
7.0 %
|
|
|
|
|
7.5 %
|
|
|
|
|
7.5 %
|
|
|
|
|
7.5 %
|
|
|
|
|
(0.5)%
|
|
|
|
|
(6.0)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
|
|
|
2.5 %
|
|
|
|
|
3.0 %
|
|
|
|
|
4.0 %
|
|
|
|
|
4.0 %
|
|
|
|
|
4.0 %
|
|
|
|
|
(1.0)%
|
|
|
|
|
(0.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CP Products
|
|
|
|
|
1.5 %
|
|
|
|
|
6.5 %
|
|
|
|
|
7.0 %
|
|
|
|
|
7.0 %
|
|
|
|
|
7.0 %
|
|
|
|
|
(0.5)%
|
|
|
|
|
(5.0)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hill's
|
|
|
|
|
4.5 %
|
|
|
|
|
7.0 %
|
|
|
|
|
4.0 %
|
|
|
|
|
4.0 %
|
|
|
|
|
4.0 %
|
|
|
|
|
3.0 %
|
|
|
|
|
(2.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Emerging Markets (1)
|
|
|
|
|
2.0 %
|
|
|
|
|
10.5 %
|
|
|
|
|
9.5 %
|
|
|
|
|
9.5 %
|
|
|
|
|
9.5 %
|
|
|
|
|
1.0 %
|
|
|
|
|
(8.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Developed Markets
|
|
|
|
|
1.0 %
|
|
|
|
|
2.0 %
|
|
|
|
|
3.0 %
|
|
|
|
|
3.5 %
|
|
|
|
|
3.5 %
|
|
|
|
|
(1.5)%
|
|
|
|
|
(0.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Emerging Markets include Latin America, Asia
(excluding Japan), Africa/Eurasia and Central Europe.
|
|
Table 7
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Geographic Sales Analysis Percentage Changes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31, 2013 vs 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPONENTS OF SALES CHANGE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coupons
|
|
|
|
|
|
|
|
|
|
|
|
Sales
|
|
|
|
|
12 Months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer &
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
Organic
|
|
|
|
|
As Reported
|
|
|
|
|
Organic
|
|
|
|
|
Ex-Divested
|
|
|
|
|
Trade
|
|
|
|
|
Foreign
|
|
Region
|
|
|
|
|
As Reported
|
|
|
|
|
Sales Change
|
|
|
|
|
Volume
|
|
|
|
|
Volume
|
|
|
|
|
Volume
|
|
|
|
|
Incentives
|
|
|
|
|
Exchange
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company
|
|
|
|
|
2.0 %
|
|
|
|
|
6.0 %
|
|
|
|
|
5.0 %
|
|
|
|
|
5.0 %
|
|
|
|
|
5.0 %
|
|
|
|
|
1.0 %
|
|
|
|
|
(4.0)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Europe/South Pacific
|
|
|
|
|
(0.5)%
|
|
|
|
|
(0.5)%
|
|
|
|
|
1.5 %
|
|
|
|
|
2.0 %
|
|
|
|
|
2.0 %
|
|
|
|
|
(2.5)%
|
|
|
|
|
0.5 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Latin America
|
|
|
|
|
(0.5)%
|
|
|
|
|
9.5 %
|
|
|
|
|
5.5 %
|
|
|
|
|
6.0 %
|
|
|
|
|
6.0 %
|
|
|
|
|
3.5 %
|
|
|
|
|
(9.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia
|
|
|
|
|
9.0 %
|
|
|
|
|
10.5 %
|
|
|
|
|
10.5 %
|
|
|
|
|
10.5 %
|
|
|
|
|
10.5 %
|
|
|
|
|
- %
|
|
|
|
|
(1.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Africa/Eurasia
|
|
|
|
|
1.5 %
|
|
|
|
|
7.0 %
|
|
|
|
|
8.0 %
|
|
|
|
|
8.0 %
|
|
|
|
|
8.0 %
|
|
|
|
|
(1.0)%
|
|
|
|
|
(5.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total International
|
|
|
|
|
1.5 %
|
|
|
|
|
6.5 %
|
|
|
|
|
6.0 %
|
|
|
|
|
6.0 %
|
|
|
|
|
6.0 %
|
|
|
|
|
0.5 %
|
|
|
|
|
(5.0)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
|
|
|
3.5 %
|
|
|
|
|
3.5 %
|
|
|
|
|
3.5 %
|
|
|
|
|
3.5 %
|
|
|
|
|
3.5 %
|
|
|
|
|
- %
|
|
|
|
|
- %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CP Products
|
|
|
|
|
2.0 %
|
|
|
|
|
6.0 %
|
|
|
|
|
5.5 %
|
|
|
|
|
5.5 %
|
|
|
|
|
5.5 %
|
|
|
|
|
0.5 %
|
|
|
|
|
(4.0)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hill's
|
|
|
|
|
2.5%
|
|
|
|
|
5.0 %
|
|
|
|
|
1.5 %
|
|
|
|
|
1.5 %
|
|
|
|
|
1.5 %
|
|
|
|
|
3.5 %
|
|
|
|
|
(2.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Emerging Markets (1)
|
|
|
|
|
3.0 %
|
|
|
|
|
9.5 %
|
|
|
|
|
8.0 %
|
|
|
|
|
8.0 %
|
|
|
|
|
8.0 %
|
|
|
|
|
1.5 %
|
|
|
|
|
(6.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Developed Markets
|
|
|
|
|
1.0 %
|
|
|
|
|
2.0 %
|
|
|
|
|
1.5 %
|
|
|
|
|
2.0 %
|
|
|
|
|
2.0 %
|
|
|
|
|
- %
|
|
|
|
|
(0.5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Emerging Markets include Latin America, Asia
(excluding Japan), Africa/Eurasia and Central Europe.
|
|
Table 8
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Reconciliations
|
|
|
|
|
|
|
|
For the Three Months Ended December 31, 2013 and 2012
|
|
|
|
|
|
|
|
(Dollars in Millions Except Per Share Amounts) (Unaudited)
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
|
Gross profit, GAAP
|
|
|
|
|
|
$
|
2,567
|
|
|
|
|
|
|
$
|
2,505
|
|
|
|
|
|
|
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
6
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
Gross profit, non-GAAP
|
|
|
|
|
|
$
|
2,577
|
|
|
|
|
|
|
$
|
2,511
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis Point
|
|
Gross Profit Margin
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
Change
|
|
Gross profit margin, GAAP
|
|
|
|
|
|
|
58.9
|
%
|
|
|
|
|
|
|
58.4
|
%
|
|
|
|
|
|
50
|
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
|
Gross profit margin, non-GAAP
|
|
|
|
|
|
|
59.1
|
%
|
|
|
|
|
|
|
58.6
|
%
|
|
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, General and Administrative Expenses
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
|
Selling, general and administrative expenses, GAAP
|
|
|
|
|
|
$
|
1,612
|
|
|
|
|
|
|
$
|
1,487
|
|
|
|
|
|
|
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
(106
|
)
|
|
|
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
Selling, general and administrative expenses, non-GAAP
|
|
|
|
|
|
$
|
1,506
|
|
|
|
|
|
|
$
|
1,481
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis Point
|
|
Selling, General and Administrative Expenses as a Percentage of
Net Sales
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
Change
|
|
Selling, general and administrative expenses as a percentage of Net
sales, GAAP
|
|
|
|
|
|
|
37.0
|
%
|
|
|
|
|
|
|
34.7
|
%
|
|
|
|
|
|
230
|
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
(2.5
|
%)
|
|
|
|
|
|
|
(0.1
|
)%
|
|
|
|
|
|
|
|
Selling, general and administrative expenses as a percentage of Net
sales, non-GAAP
|
|
|
|
|
|
|
34.5
|
%
|
|
|
|
|
|
|
34.6
|
%
|
|
|
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (Income) Expense, Net
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
|
Other (income) expense, net, GAAP
|
|
|
|
|
|
$
|
63
|
|
|
|
|
|
|
$
|
76
|
|
|
|
|
|
|
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
(61
|
)
|
|
|
|
|
|
|
(81
|
)
|
|
|
|
|
|
|
|
Charge for a French competition law matter
|
|
|
|
|
|
|
(5
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Other (income) expense, net, non-GAAP
|
|
|
|
|
|
$
|
(3
|
)
|
|
|
|
|
|
$
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Profit
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
% Change
|
|
Operating profit, GAAP
|
|
|
|
|
|
$
|
892
|
|
|
|
|
|
|
$
|
942
|
|
|
|
|
|
|
(5
|
%)
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
173
|
|
|
|
|
|
|
|
89
|
|
|
|
|
|
|
|
|
Charge for a French competition law matter
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
Operating profit, non-GAAP
|
|
|
|
|
|
$
|
1,074
|
|
|
|
|
|
|
$
|
1,035
|
|
|
|
|
|
|
4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis Point
|
|
Operating Profit Margin
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
Change
|
|
Operating profit margin, GAAP
|
|
|
|
|
|
|
20.5
|
%
|
|
|
|
|
|
|
22.0
|
%
|
|
|
|
|
|
(150
|
)
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
3.9
|
%
|
|
|
|
|
|
|
2.0
|
%
|
|
|
|
|
|
|
|
Charge for a French competition law matter
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
|
Operating profit margin, non-GAAP
|
|
|
|
|
|
|
24.6
|
%
|
|
|
|
|
|
|
24.1
|
%
|
|
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income Attributable to Colgate-Palmolive Company
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
% Change
|
|
Net income attributable to Colgate-Palmolive Company, GAAP
|
|
|
|
|
|
$
|
564
|
|
|
|
|
|
|
$
|
598
|
|
|
|
|
|
|
(6
|
%)
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
125
|
|
|
|
|
|
|
|
70
|
|
|
|
|
|
|
|
|
Charge for a French competition law matter
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
Net income attributable to Colgate-Palmolive Company, non-GAAP
|
|
|
|
|
|
$
|
697
|
|
|
|
|
|
|
$
|
671
|
|
|
|
|
|
|
4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Per Common Share, Diluted (1) (2)
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
% Change
|
|
Diluted earnings per common share, GAAP
|
|
|
|
|
|
$
|
0.60
|
|
|
|
|
|
|
$
|
0.63
|
|
|
|
|
|
|
(5
|
%)
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
0.14
|
|
|
|
|
|
|
|
0.07
|
|
|
|
|
|
|
|
|
Charge for a French competition law matter
|
|
|
|
|
|
|
0.01
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Diluted earnings per common share, non-GAAP
|
|
|
|
|
|
$
|
0.75
|
|
|
|
|
|
|
$
|
0.70
|
|
|
|
|
|
|
7
|
%
|
(1) The impact of non-GAAP adjustments on the diluted
earnings per share may not necessarily equal the difference between
"GAAP" and "non-GAAP" as a result of rounding.
(2) As a result of the two-for-one stock split, effective May
15, 2013, all historical per share data and number of shares were
retroactively adjusted. Diluted earnings per share were computed
independently for each quarter presented.
|
Table 9
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Reconciliations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Twelve Months Ended December 31, 2013 and 2012
|
|
|
|
|
|
|
|
(Dollars in Millions Except Per Share Amounts) (Unaudited)
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
|
Gross profit, GAAP
|
|
|
|
|
|
$
|
10,201
|
|
|
|
|
|
|
$
|
9,932
|
|
|
|
|
|
|
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
32
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
15
|
|
|
|
|
|
|
|
24
|
|
|
|
|
|
|
|
|
Business realignment and other cost-saving initiatives
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
|
Gross profit, non-GAAP
|
|
|
|
|
|
$
|
10,248
|
|
|
|
|
|
|
$
|
9,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis Point
|
|
Gross Profit Margin
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
Change
|
|
Gross profit margin, GAAP
|
|
|
|
|
|
|
58.6
|
%
|
|
|
|
|
|
|
58.1
|
%
|
|
|
|
|
|
50
|
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
0.2
|
%
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
0.2
|
%
|
|
|
|
|
|
|
|
Gross profit margin, non-GAAP
|
|
|
|
|
|
|
58.8
|
%
|
|
|
|
|
|
|
58.3
|
%
|
|
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, General and Administrative Expenses
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
|
Selling, general and administrative expenses, GAAP
|
|
|
|
|
|
$
|
6,223
|
|
|
|
|
|
|
$
|
5,930
|
|
|
|
|
|
|
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
(137
|
)
|
|
|
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
Business realignment and other cost-saving initiatives
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(14
|
)
|
|
|
|
|
|
|
|
Selling, general and administrative expenses, non-GAAP
|
|
|
|
|
|
$
|
6,086
|
|
|
|
|
|
|
$
|
5,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis Point
|
|
Selling, General and Administrative Expenses as a Percentage of
Net Sales
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
Change
|
|
Selling, general and administrative expenses as a percentage of Net
sales, GAAP
|
|
|
|
|
|
|
35.7
|
%
|
|
|
|
|
|
|
34.7
|
%
|
|
|
|
|
|
100
|
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
(0.8
|
%)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Business realignment and other cost-saving initiatives
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(0.1
|
%)
|
|
|
|
|
|
|
|
Selling, general and administrative expenses as a percentage of Net
sales, non-GAAP
|
|
|
|
|
|
|
34.9
|
%
|
|
|
|
|
|
|
34.6
|
%
|
|
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (Income) Expense, Net
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
|
Other (income) expense, net, GAAP
|
|
|
|
|
|
$
|
422
|
|
|
|
|
|
|
$
|
113
|
|
|
|
|
|
|
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
(202
|
)
|
|
|
|
|
|
|
(81
|
)
|
|
|
|
|
|
|
|
Venezuela devaluation charge
|
|
|
|
|
|
|
(172
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Charge for a French competition law matter
|
|
|
|
|
|
|
(23
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Business realignment and other cost-saving initiatives
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
Other (income) expense, net, non-GAAP
|
|
|
|
|
|
$
|
22
|
|
|
|
|
|
|
$
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Profit
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
% Change
|
|
Operating profit, GAAP
|
|
|
|
|
|
$
|
3,556
|
|
|
|
|
|
|
$
|
3,889
|
|
|
|
|
|
|
(9
|
%)
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
371
|
|
|
|
|
|
|
|
89
|
|
|
|
|
|
|
|
|
Venezuela devaluation charge
|
|
|
|
|
|
|
172
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Charge for a French competition law matter
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
24
|
|
|
|
|
|
|
|
|
Business realignment and other cost-saving initiatives
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
21
|
|
|
|
|
|
|
|
|
Operating profit, non-GAAP
|
|
|
|
|
|
$
|
4,140
|
|
|
|
|
|
|
$
|
4,023
|
|
|
|
|
|
|
3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis Point
|
|
Operating Profit Margin
|
|
|
|
|
|
|
2013
|
|
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
Change
|
|
Operating profit margin, GAAP
|
|
|
|
|
|
|
20.4
|
%
|
|
|
|
|
|
|
22.8
|
%
|
|
|
|
|
|
(240
|
)
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
2.2
|
%
|
|
|
|
|
|
|
0.5
|
%
|
|
|
|
|
|
|
|
Venezuela devaluation charge
|
|
|
|
|
|
|
1.0
|
%
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Charge for a French competition law matter
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
|
Business realignment and other cost-saving initiatives
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
0.1
|
%
|
|
|
|
|
|
|
|
Operating profit margin, non-GAAP
|
|
|
|
|
|
|
23.8
|
%
|
|
|
|
|
|
|
23.5
|
%
|
|
|
|
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income Attributable to Colgate-Palmolive Company
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
% Change
|
|
Net income attributable to Colgate-Palmolive Company, GAAP
|
|
|
|
|
|
$
|
2,241
|
|
|
|
|
|
|
$
|
2,472
|
|
|
|
|
|
|
(9
|
%)
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
278
|
|
|
|
|
|
|
|
70
|
|
|
|
|
|
|
|
|
Venezuela devaluation charge
|
|
|
|
|
|
|
111
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Charge for a French competition law matter
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
12
|
|
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
|
Business realignment and other cost-saving initiatives
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
14
|
|
|
|
|
|
|
|
|
Net income attributable to Colgate-Palmolive Company, non-GAAP
|
|
|
|
|
|
$
|
2,665
|
|
|
|
|
|
|
$
|
2,574
|
|
|
|
|
|
|
4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Per Common Share, Diluted (1) (2)
|
|
|
|
|
|
2013
|
|
|
|
|
|
2012
|
|
|
|
|
|
% Change
|
|
Diluted earnings per common share, GAAP
|
|
|
|
|
|
$
|
2.38
|
|
|
|
|
|
|
$
|
2.57
|
|
|
|
|
|
|
(7
|
%)
|
|
2012 Restructuring Program
|
|
|
|
|
|
|
0.30
|
|
|
|
|
|
|
|
0.07
|
|
|
|
|
|
|
|
|
Venezuela devaluation charge
|
|
|
|
|
|
|
0.12
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Charge for a French competition law matter
|
|
|
|
|
|
|
0.03
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Costs related to the sale of land in Mexico
|
|
|
|
|
|
|
0.01
|
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
|
|
Business realignment and other cost-saving initiatives
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
|
|
Diluted earnings per common share, non-GAAP
|
|
|
|
|
|
$
|
2.84
|
|
|
|
|
|
|
$
|
2.68
|
|
|
|
|
|
|
6
|
%
|
(1) The impact of non-GAAP adjustments on the diluted
earnings per share may not necessarily equal the difference between
"GAAP" and "non-GAAP" as a result of rounding.
(2) As a result of the two-for-one stock split, effective May
15, 2013, all historical per share data and number of shares were
retroactively adjusted. Diluted earnings per share were computed
independently for each quarter and the year to date period presented. As
a result of the stock split, changes in shares outstanding during the
year and rounding, the sum of the quarters' earnings per share may not
necessarily equal the earnings per share for the year to date period.
Copyright Business Wire 2014